Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
Retirement of STK-7 Dysphagia Screen STK-07
Earliest principal procedure time/first pass time CSTK
Positive Brain Image CSTK
Abstraction for Last Known Well STK-04
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Documentation for tPA exclusion STK, STK-04
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
History of low vertical incision documented BUT no documentation of classical incision. PC-01
Functional Status at Discharge ACHF
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
COVID-19 CSTK
Stroke that occurs after admission CSTK
What number should we enter for the denominator? HCSS-6
Support System ACHF
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
PSC CSTK 01 population CSTK, CSTK-01
Admitted for elective carotid intervention STK
doucumentation of ich and hunt hess CSTK-03
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
Time Last Known Well STK
Will Evidence of Atherosclerosis remain a data element? STK-06
First Radiographic Image, CSTK 07 STK
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
STK-6 "Evidence of Atherosclerosis" STK
CSTK 3 CSTK, CSTK-03
Stroke VTE Prophylaxis STK-01
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
Abstraction Tools ASR-OP-1
Time NIHSS performed CSTK-01
Is intensive dosing of statin required to meet STK-6? STK
Why has this indicator has changed to include the word "elective"? STK
Statin prescibed the day after discharge STK-06, STK-08
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
Written discharge instructions for warfarin therapy VTE-05
Sampling Methodology for Stroke STK
ICD-9-CM Code 433.10 STK
Can I use VTE used during the Observation, given prior to hospital admission STK-1
STK-5 Antithrombotic - LOVENOX SQ STK
CSTK 4 Denominator Population CSTK-04
Documentation of Stroke Education STK-08
Sampling Requirements for CSTK CSTK
Why are there not more contraindications to vaginal deliveries? PC
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
Patients transferred after t-PA STK
Expired after discharge CSTK-02
How do I determine my firm group? HCSS
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
Can an addendum be added to the medical record? STK-01
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
Data Abstraction for "Last Known Well" STK
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
HBIPS Event Dates Prior to Admission HBIPS
What is the Date and Time of Last Well Known? STK-04
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
Will Primary Stroke Certification continue? STK
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
thyroid CA PC-01
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
Discharge Code and Transfers of Patients STK-OP
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
Date Last Known Well STK
Antithrombotic Administration after t-PA STK-05
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Stroke Measures STK-7 and STK-9 STK
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
Do I need to enter this data again or can I just start with January? HCSS
First NIHSS performed days after admission CSTK-01
HBIPS Discharge Status HBIPS
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
Is admission day counted as day 1 for STK-1? STK
Time Last Know Well -Stroke STK
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
Abstraction for Clinical Trial (STK ) STK
Clarification of CSTK-1 Measure Population Requirements CSTK-01
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
ICH score documentation CSTK-03b
mRS CSTK
STK-6 Data Entry in CMIP for Q1 2010 STK
Follow-up to UserQuestionId03Stk100984 STK-04
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
MER Attempted During this Encounter - Clot Dissolved CSTK-11
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
STK-4 IV Thrombolytic Therapy STK
Last Known Well STK-04
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
Stroke Module STK
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
Multiple Procedure Times CSTK, CSTK-01
Assessed for Rehabaliitation Services STK-10
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
Sampling when both STK and CSTK are collected by a HCO CSTK
Need information about the required import file specifications BM
NIHSS Timed After Discharge CSTK-01
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
Follow-up to UserQuestionId03Stk100628 STK
What constitutes a failed thrombectomy CSTK-11
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
Unable to Calculate LDL Value Due to High Triglycerides STK-06
Reason for No VTE Prophylaxis STK, STK-01
Documentation for Rehabilitation Assessment STK-10
Risk of Violence to Self HBIPS, HBIPS-1
Patient Population CSTK
HBIPS-1 Timeframe for Screening Questions HBIPS
Why aren't more exclusions to elective delivery considered? PC
STK 10 Assessed for rehabilitation STK-10
Follow-up to UserQuestion102705 CSTK
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Number of cases needed for submission BM
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
Triglyceride >400mg/dL STK
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
Continuing Care Plan Document Questions HBIPS
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
Time of the teleneurology NIHSS CSTK-01
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
Documentation for Stroke Education HF-1
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
Does the following documentation meet education regarding Risk factors for stroke? STK
Birth Weight suggested Sources PC-06
Clarification of data elements needed CSTK-05b, CSTK-07
Patient Referral to Next Level of Care Provider HBIPS
DVT Prophylaxis and Ambulation STK, STK-01
TEDS for VTE Prophylaxis STK, STK-01
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
Procedure Time Inclusion Terms CSTK-03
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Definition of validated and non-validated screening tool for substance use SUB-01
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
Define who is considered a stroke team for STK 4. STK
Follow-up to UserQuestionId03Vte101043 VTE-05
Recommended ways to obtain mRS CSTK, CSTK-02
Elective carotid intervention documentation STK
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
Comprehensive Stroke (CSTK Sub-Populations) CSTK
Is this considered a stroke clinical trial patient? STK
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Refusal of SCD's STK, STK-01
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Last Known Well Y/N? STK-4
Documentation of Last Known well STK, STK-4
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
Last Known Well STK, STK-04
Statin therapy for patients 75yrs and older STK
Stroke Measure Requirements STK
Does all medical record documentation need to be dated and timed? STK
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
What should we do when conflicting or multiple times of last known well are documented? STK-04
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
Data Element- Violence Risk to Self HBIPS
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
Reason for Not Initiating IV Thrombolytic STK
Assessed for Rehabilitation STK
Pneumonia diagnosis: ED/Direct Admint PN
Psychiatic Care Setting -Patient Inclusion HBIPS
activity charting ACHF
Pre-transfusion platelet count allowable value BM-04b
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Stroke Education Documentation Examples STK-08
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
Rationale for Code Stroke Form as the Priority Data Source STK-4
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
Procedures Performed During Hospitalization ACHF
STK-10 Assessed for Rehabilitation Services STK-10
Rehabilitation Assessment STK
Arrival time for transferred patients CSTK-07
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
Multiple TICI reperfusion grades CSTK-08
Transfer in patients that are intubated CSTK-01
Pre-anemia screening BM
Patient Ambulatory At End of Hospital Day 2 STK
Which version of the specifications should be used for stroke data collection? STK
Importance of exclusive breast milk feeding PC
Exclusive breast milk feeding definition PC
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
Dabigatran (PRADAXA use in Stroke Patients) STK
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
How is Length of Stay (LOS calculated for STK-1?) STK-01
Jan 2012 Follow-up monitoring VTE-05
Statins at Discharge STK-06
Mother's choice not to breast feed PC-05
Who should perform mRS? CSTK-02
One Episode of Care and Thrombolytic Therapy Administration STK
Hunt and Hess & ICH Score Documentation CSTK-03
CSTK4 documentation time? CSTK-04
Evidence of Atherosclerosis STK
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
Stroke core measure data for PSC hospitals STK
NIHSS Score Clarification CSTK-01
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
NIHSS time STK
MER Eligibility CSTK
Arrival time Abstraction. CSTK-11
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
Continuing Care Plan - Reason for Hospitalization HBIPS
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
Data abstraction for VTE Prophylaxis when administered prior to admission STK
Numerator Statement HCSS
Reason for extending IV tPA STK-4
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
Question regarding the new STK OP 1 Measure STK-OP
Can we use E/M code 99211? ACHF
Next Level of Care Provider Same as Hospital Provider HBIPS
Documentation Compliance for IV t-PA STK, STK-04
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
Failed attempt at thrombectomy CSTK-08
Admission Date STK-01
NIHSS versus mNIHSS CSTK-05
Last known well when symptoms resolve then reoccur STK
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
ABstraction for Date Last Known Well STK
CSTK Procedure Times CSTK
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
Date/Time of First Pass for CSTK-7 CSTK
Time Last Known Well is after hospital arrival STK-04
Please submit all outpatient questions to QnetQuest.org OP
Sampling Requirements for CSTK CSTK
What value should be selected when VTE prophylaxis is administered several days after admission? STK
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
Activity specifics ACHF
SCIP questions related to the April 2010 manual SCIP
Graduated Compression Stocking (GCS) STK
Reason for not giving Nimodipine within 24 hours CSTK
Arrival Time for STK, CSTK and STK-OP Measures STK
What is the Admission Date? STK
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
CSTK-01 Procedures and Timing 1 calculation CSTK-01
What is the Date and Time Last Known Well? STK-04
Questions about sampling? ACHF
Pradaxa (dabigatran prescribed at discharge) STK-02
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
What would I document as Last Known Well? STK, STK-4
Comparative Data for Stroke Measures STK
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
Reason for not prescribing antithrombotic therapy at hospital discharge STK
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Reason for Not Administering Antithrombotic Therapy? STK
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
Time Last Known Well - Conflicting Physician Documentation STK-04
Discharged on Anticoagulation Therapy STK
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
Referral to Next Level of Care HBIPS
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Clairfy time to recanalization CSTK, CSTK-07
SUB 2 SUB
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
Documentation added to D/C summary after discharge STK-6
Inter-rater Reliability and Chart Re-asbstraction STK
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Elective Carotid Intervention STK
Positive over negative findings STK-OP
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
What terms can be used for Comfort Measures Only? STK
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
HBIPS- Restraint and Seclusion in ED HBIPS-3
Documention of Stroke education at discharge, STK-08
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
Stroke Diagnosed Mid-Hospital Stay STK-5
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
Last Known Well Version 5.2 STK-4
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Optimal Medication Management ACHF
Code 433.10 and Transient Ischemic Attack STK
IV Alteplase STK-OP
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
How to abstact Last Known Well when there is too much information? STK
Are patients that stroke while an inpatient included in the measure population? STK
Procedure codes for HF outpatients ACHF
Primary Stroke Certification and Transition to Stroke Core Measures STK
Covid Vaccine Audit HCSS
Late Coded Stroke STK-4 and STK-5 STK, STK-4
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
Non Aneurysmal SAH Documentation CSTK-06
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
Multiple EMRs HBIPS
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine